New treatment for relapsing MS: administration of a bolus of B-cell depleting antibodies every six months reduces rates of relapse by 47% and slows disease progression in two Phase III trials.

See the source article by following the link below:
New treatment for relapsing MS: administration of a bolus of B-cell depleting antibodies every six months reduces rates of relapse by 47% and slows disease progression in two Phase III trials.